SCHEMBL7077

SCHEMBL7077

COc1cccc2c1SCCC2=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.53
ALDH1A1 P00352 5/20 0.53
HTT P42858 2/20 0.46
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
USP2 O75604 2/20 0.44
S100A4 P26447 1/20 0.44
ACHE P22303 1/20 0.41
TOP1 P11387 1/20 0.41
HPGD P15428 1/20 0.39
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA7 P43166 1/20 0.38
CA9 Q16790 1/20 0.38
POLL Q9UGP5 1/20 0.38
MAPT P10636 3/20 0.37
APAF1 O14727 1/20 0.37
MITF O75030 1/20 0.37
LMNA P02545 1/20 0.37
EGFR P00533 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9464624 0.79 KDM4E (0.57) KDM4EALDH1A1HTTMEN1KMT2A
SCHEMBL5635241 0.77 MEN1 (0.47) KDM4EALDH1A1HTTMEN1KMT2A
SCHEMBL10050656 0.76 KDM4E (0.53) KDM4EALDH1A1HTTMEN1KMT2A
SCHEMBL10857685 0.75 DRD2 (0.40) KDM4EALDH1A1HPGDCA1CA2
SCHEMBL6605669 0.74 KDM4E (0.54) KDM4EALDH1A1HTTMEN1KMT2A
SCHEMBL10050646 0.74 ELANE (0.33) KDM4EALDH1A1HTTGAA
SCHEMBL6924 0.74 NOTUM (0.39) KDM4EALDH1A1HTTMEN1KMT2A
SCHEMBL7502 0.74 PARP10 (0.39) KDM4EALDH1A1HTTMEN1KMT2A
SCHEMBL10464 0.74 MAPT (0.46) KDM4EALDH1A1HTTMEN1KMT2A
SCHEMBL23861125 0.73 ALDH1A1 (0.53) KDM4EALDH1A1HTTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0228920-B1 THIOCHROMAN DERIVATIVE, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT ADIR ET COMPAGNIE (FR) 1989-05-03 EP claimed
CN-115836077-B Oxazaspiro derivative, preparation method thereof and application thereof in medicine 江苏恒瑞医药股份有限公司 2025-05-13 CN disclosed
US-20230234962-A1 OXA-AZASPIRO DERIVATIVE, AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF JIANGSU HENGRUI PHARMACEUTICALS CO., LTD. (CN) 2023-07-27 US disclosed
US-20230234962-A1 OXA-AZASPIRO DERIVATIVE, AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF JIANGSU HENGRUI PHARMACEUTICALS CO., LTD. (CN) 2023-07-27 US disclosed
CN-113754685-B Dihydrothiochromene pyrazole derivative, preparation method and application thereof in medicine 江苏恒瑞医药股份有限公司 2023-06-16 CN disclosed
EP-4190789-A1 OXA-AZASPIRO DERIVATIVE, AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF Jiangsu Hengrui Pharmaceuticals Co., Ltd. (CN) 2023-06-07 EP disclosed
EP-4190789-A1 OXA-AZASPIRO DERIVATIVE, AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF Jiangsu Hengrui Pharmaceuticals Co., Ltd. (CN) 2023-06-07 EP disclosed
CN-115835863-A Oxaazabicyclic derivatives, preparation method and application thereof in medicines 江苏恒瑞医药股份有限公司 2023-03-21 CN disclosed
CN-112759586-B Chiral thiochroman-4-ketone compound, and preparation method and application thereof 河南大学 2022-05-17 CN disclosed
WO-2022022630-A1 OXA-AZASPIRO DERIVATIVE, AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF 江苏恒瑞医药股份有限公司 2022-02-03 WO disclosed
US-20120238545-A1 TRICYCLIC PYRAZOL AMINE DERIVATIVES MERCK SERONO SA (CH) 2012-09-20 US disclosed
US-20120238545-A1 TRICYCLIC PYRAZOL AMINE DERIVATIVES MERCK SERONO SA (CH) 2012-09-20 US disclosed
US-20120238545-A1 TRICYCLIC PYRAZOL AMINE DERIVATIVES MERCK SERONO SA (CH) 2012-09-20 US disclosed
EP-2499146-A1 TRICYCLIC PYRAZOL AMINE DERIVATIVES Merck Serono S.A. (CH) 2012-09-19 EP disclosed
WO-2011058149-A1 TRICYCLIC PYRAZOL AMINE DERIVATIVES MERCK SERONO S.A. (CH) 2011-05-19 WO disclosed
WO-2011058149-A1 TRICYCLIC PYRAZOL AMINE DERIVATIVES MERCK SERONO S.A. (CH) 2011-05-19 WO disclosed
EP-0627438-B1 METHANEDIPHOSPHONATE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND PHARMACEUTICAL USE THEREOF TORAY INDUSTRIES (JP) 1999-01-13 EP disclosed
US-5565440-A ANTIINFLAMMATORY, ANTIPYRITIC, ANALGESIC, ANTIRHEUMATIC, ANTIARTHRITIC OR ANTIOSTEOPROSIS AGENT TORAY INDUSTRIES, INC. (JP) 1996-10-15 US disclosed
EP-0627438-A1 METHANEDIPHOSPHONATE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND PHARMACEUTICAL USE THEREOF TORAY INDUSTRIES, INC. (JP) 1994-12-07 EP disclosed
US-4703057-A HYPERTENSION, ANGINA PECTORIS, ARRHYTHMIA, CARDIOVASCULAR DISORDERS ADIR ET COMPAGNIE (FR) 1987-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120238545-A1 TRICYCLIC PYRAZOL AMINE DERIVATIVES PI4KB, MTOR, PI4KA KDM4E 1093/4885ALDH1A1 3185/4885HTT 3430/4885
US-20230234962-A1 OXA-AZASPIRO DERIVATIVE, AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF PIK3CD, PIK3CA, PIK3R5 KDM4E 3238/4885ALDH1A1 704/4885HTT 4290/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.